Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Assessment of MGMT methylation status using high-performance liquid chromatography in newly diagnosed glioblastoma

Fig. 4

Kaplan–Meier curve based on MGMT promoter methylation status determined using frozen samples. For region 1, patients whose tumors were methylated exhibited significantly longer PFS than patients with unmethylated tumors (a). For region 2, patients whose tumors were methylated exhibited significantly longer OS and PFS than patients with unmethylated tumors (b). For region 3, no statistically significant differences in survival were observed between methylated and unmethylated tumors (c)

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us